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Abstract

Purpose of Study: To evaluate the left superior pulmonary venous ridge
length (RL) and the left atrial appendage fractal dimension (LAA FD) as
predictors of cardioembolic ischemic stroke (CVA) and transient ischemic attack
(TIA) in patients with atrial fibrillation (AF).
Materials, Methods and Procedures: A multicenter, retrospective multicenter study was conducted on patients with AF who underwent cardiac CT
prior to catheter ablation between 01/01/2010 and 12/31/2015. Patients were
grouped by presence or absence of prior CVA/TIA. Patients with mitral stenosis,
prior mechanical aortic valve replacement, ascending aortic arch atheroma, highrisk patent foramen ovale, history of atrial septal repair or device, preexisting
LAA thrombus or intra-cardiac tumor, or prior open-heart surgery were
excluded. Further exclusion was performed for patients with sub-optimal or
unavailable cardiac CT imaging by investigators blinded to clinical data. Blinded
investigators obtained RL by measuring the distance between the left superior
pulmonary venous ostium and the internal ostium of the left atrial appendage.
LAA FD was calculated using semi-automated volume rendering and processing
software (ImageJ, Bethesda, MD) [1] and LAA FD are presented as means (95%
confidence interval) and were compared between groups using unpaired t-tests.
Logistic regression analysis was used to construct receiver operating curves and to
assess the abilities of RL and LAA FD to predict prior CVA/TIA.
Results: 225 patients met inclusion criteria. Mean RL were 4.32 (3.804.93) and 5.20 (4.93-5.48) for patients with (n=24; mean age: 59.4; 70.8% male)
and without (n=165; mean age: 59.3; 75.4% male) prior CVA/TIA, respectively
(p=0.033). Mean LAA FD were 2.29 (95% CI: 2.24-2.34) and 2.33 (2.32-2.34)
for patients with (n=22; mean age: 60.3; 68.2% male) and without (n=171; mean
age: 59.3; 74.9% male) prior CVA/TIA, respectively (p=0.052). In a regression
model including LAA FD, RL, and established predictive markers, only RL
predicted prior CVA/TIA (OR 0.73; 0.54 to 0.98; p=0.034).
Discussion: Lower RL values were associated with prior CVA/TIA, whereas
LAA FD values were similar between patients with AF with and without prior
CVA/TIA. RL is a novel marker that may refine clinical decision-making
regarding anticoagulation goals and treatment decisions for patients with AF.
Future studies with larger samples should investigate the clinical utility of RL
to improve CVA/TIA risk stratification of patients with AF and prospectively
reduce the incidence of CVA/TIA in this population.

Singh et al.

48

Singh et al.

The Pulmonary Venous Ridge Length to Stratify Stroke Risk in Atrial Fibrillation

Keywords

Atrial fibrillation, Left atrial appendage, Stroke, CVA,
Ridge length

Introduction

The mechanism of cardioembolic ischemic stroke (CVA)
in atrial fibrillation (AF) is well-validated. Among patients
with AF, left atrial thromboembolism is the mechanism
underlying CVA in approximately 70% of cases [2] with up
to 90% of these specifically originating from the left atrial
appendage (LAA) based on autopsy and radiographic studies
[3].
Therapeutic anticoagulation is the principle strategy
used to prevent CVA in patients with AF deemed to be at
increased risk. The decision to treat is primarily informed
by a validated clinical decision-making tool known as the
CHA2DS2-VASc scoring system to estimate an individual
patient’s annual risk of CVA based on the presence of certain
risk factors (heart failure, hypertension, age, diabetes mellitus,
vascular disease, female gender). A CHA2DS2-VASc score of
2 or greater is considered an indication to initiate therapeutic
anticoagulation in most patients whereas a score of 0 indicates
low-dose aspirin monotherapy [2-3]. While well-validated
in high-risk populations, large retrospective meta-analyses
have reported poor predictive value for intermediate-risk
patients, or patients with CHA2DS2-VASc scores of 1 [4, 5].
CHA2DS2-VASc scores are similarly imprecise in identifying
high-risk patients who would receive net clinical benefit from
long-term anticoagulation [4, 5].
Radiographic LAA structural parameters have previously
been studied to predict CVA/TIA among patients with AF.
LAA volume has long been considered an independent marker
of thromboembolic risk in AF [6-8]. Additionally, patients
with suspected cardioembolic CVA often demonstrated
increased LAA volume and single-lobed LAA morphology
[9].
Retrospective studies have identified archetypal LAA
morphologies (Figure 1) derived from cross-sectional imaging
and assessed their role in predicting CVA risk in patients with
AF. Di Biase and colleagues reported a negative association
between CVA risk and presence of the ‘chicken wing’ LAA
morphology that persisted when controlling for other risk
factors in multivariate analysis [10]. One study attributed
the higher risk ‘chicken wing morphology’ to higher maximal
LAA empty flow velocity [11]. Significant data heterogeneity
and imprecision have been cited as major limitations to this
approach to studying LAA morphology [12].
In figure 1, the four originally described archetypal LAA
morphologies volume-rendered and segmented from cardiac
computed tomographic angiographic (CCTA) studies. LAA
reconstructions are designated as windsock, chicken wing,
broccoli, and cactus morphologies (left to right). Retrospective
studies have associated lower risk of CVA with presence of the
chicken wing LAA morphology [10].
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Figure 1: Volume-rendered LAA segmentations (left to right): Wind sock
morphology, chicken wing morphology, broccoli morphology, and cactus
morphology.

Fractal dimensions (FD) are ratios that provide statistical
indices of complexity by measuring how the complexity of
each object varies with each measuring scale. FDs have been
applied to study heterogeneous biological objects derived
from radiographic and histologic modalities where they have
been shown to yield highly reproducible and accurate data
[13]. To the best of our knowledge, the present study is the
first attempt to apply fractal analysis to evaluate the role of
LAA morphology in CVA risk among patients with AF and
to stratify stroke risk in AF. We hypothesize that a higher
FD reflects a more complex or irregularly structured LAA
endocardial surface that is more likely to produce abnormal
blood flow and serve as a nidus for thromboembolism.
Therefore the LAA FD may be a clinically useful marker of
CVA risk in patients with AF.
The relationships between the LAA and other
atrial features have been investigated as predictors of
thromboembolism in atrial fibrillation [14-22]. LAA “takeoff ” was defined by Nedios et al. as whether the superior and
inferior LAA ostial ridges were “higher” or “lower” than the
respective left superior pulmonary vein (LSPV) and the right
superior pulmonary vein (RSPV) [17]. Nedios et al. proposed
a pathophysiologic mechanism of tachycardia-mediated
thrombogenic flow in patients with superior LAA “takeoff ”
anatomy, and that inferior LAA “takeoff ” anatomy is protective
against cardioembolic events in AF [17]. Electrophysiologists
at [institution blinded] observed variation in both size and
thickness of the ridge of tissue interfacing between the
LSPV and the LAA upon review of CCTA studies prior to
catheter-based ablation procedures. A systematic literature
review demonstrated no prior studies attempting to classify
or investigate this structure, and the pulmonary venous ridge
length (RL) is proposed as the designation of the interface
between the LSPV and the LAA.
The purpose of this study is to investigate the abilities
of the LAA FD and RL to predict CVA and/or transient
ischemic attack (TIA) in patients with AF.

Methods

A multicenter, retrospective study was performed using
patients with AF who underwent both cardiac CT and
catheter ablation between 01/01/2010 and 12/31/2015. 205
patients from [institution blinded] and 20 patients from
[institution blinded] were stratified based on the presence or
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absence of prior CVA/TIA.
Exclusion was performed based on the presence of mitral
stenosis, prior mechanical aortic valve replacement, ascending
aortic arch atheroma, high risk patent foramen ovale, history
of atrial septal repair or device, preexisting LAA thrombus,
intracardiac tumor, or prior open-heart surgery. Independent
investigators blinded to radiographic data completed a
retrospective chart review for the cohort, obtaining baseline
characteristics of age, patient sex, and CHA2DS2-VASc scores.
Corresponding patient CCTA studies were de-identified and
randomized, and further exclusion was performed on the basis
of study availability by investigators blinded to clinical data.

3). Two-dimensional metrics were instantly compiled using
custom-designed running summation, average, and standard
deviation scripts.
The native measurement tool from the open-source
image processing software (3D Slicer [23]) was utilized to
measure RL from CCTA studies. RL was measured on axial
CCTA section as the shortest distance (width) perpendicular
to the vector direction of the ridge wall extending between
the LSPV and the LAA (Figures 4-9). Two board-certified
electrophysiologists and one board-certified cardiothoracic
radiologist measured RL. Ground truth labels were determined

Open-source image processing with volume-rendering
software was utilized (3D Slicer [23]) to analyze CCTA
studies. On three-view analysis (coronal, sagittal, and axial),
manual binary selection of cardiac blood pool and noncontrast phases was performed (Figure 2). A native automated
thresholding function for total binarization was then applied,
and a cropped three-dimensional volume was rendered
following manual cropping by trained investigators at the level
of each LAA ostium.

Figure 4: RL measurement derived from CCTA measuring shortest length
(mm) from the LAA to the LSPV perpendicular to axis of the pulmonary
venous ridge (RL=6.01).

Figure 2: Three-view view of CCTA study for binarization and semiautomated LAA segmentation.

Following the generation of a cropped volume and threedimensional model, volumes were saved as NRRD files that
were imported into a custom batch processor (Figure 3)
leveraging an open source fractal analysis algorithm and Image
J (NIH [1]) to compute LAA FDs for each segmentation.

Figure 5: RL=3.38 in a patient with prior CVA.

Figure 3: Batch processor schematic of LAA segmentations to generate
LAA FD values.

Schematic depicting the batch-processing algorithm we
developed and utilized to generate LAA FD values (Figure
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Figure 6: RL=7.17 in a patient with no prior CVA.
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logistic regression analysis was used to identify clinical
variables predictive of prior CVA/TIA. Classifier values were
assessed through receiver operating characteristic analysis to
calculate the area-under- the-curve.

Results

Significantly fewer subjects had histories of CVA/
TIA compared to those without. Baseline study cohort
characteristics were otherwise similar (Table 1). Mean RL were
4.32 (3.80-4.93) and 5.20 (4.93-5.48) for patients with (n=24;
Table 1: Study cohort characteristics.

Figure 7: RL=5.32 in a patient with no prior CVA.

LAA FD

Figure 8: RL=3.33 in a patient with no prior CVA.

RL

Past CVA/
TIA
n = 22

No Past
CVA/TIA
n = 171

Past CVA/
TIA
n = 24

No Past
CVA/TIA
n = 175

Male, No. (%)

15 (68.2)

128 (74.9)

17 (70.8)

132 (75.4)

Age, mean (SD)

60.3 (10.1)

59.3 (10.3)

59.4 (10.6)

59.3 (9.9)

Median
CHA2DS2VASc Score*

2 (1 to 3)

2 (1 to 2)

1.5 (1 to 3)

1 (1 to 3)

Median
CHA2DS2VASc Score*
(Interquartile
Range)

2 (1 to 3)

2 (1 to 2)

1.5 (1 to 3)

1 (1 to 3)

mean age: 59.4; 70.8% male) and without (n=165; mean age:
59.3; 75.4% male) prior CVA/TIA, respectively (p=0.033).
Mean LAA FD were 2.29 (95% CI: 2.24-2.34) and 2.33
(2.32-2.34) for patients with (n=22; mean age: 60.3; 68.2%
male) and without (n=171; mean age: 59.3; 74.9% male) prior
CVA/TIA, respectively (p=0.052). In a regression multivariate
analysis model including LAA FD, RL, CHA2DS2-VASc
scores, and individual CHA2DS2-VASc scoring criteria, only
RL was a significant predictor of prior CVA/TIA (OR 0.73;
0.54 to 0.98; p=0.034) (Table 2).

Discussion

Figure 9: RL=3.53 in a patient with no prior CVA.

by mean RLs with consensus measurements. Inter-rater
variability was not formally statistically evaluated.
Statistical analyses were performed using Prism 6
(GraphPad Software, San Diego, CA). The unpaired student’s
t-test was used to compare continuous variables. Multivariate

A lower RL predicted prior CVA/TIA in patients with
AF whereas LAA FD was similar between patients with and
without prior CVA/TIA.
Our findings serve as proof-of-concept for the semiautomated workflow developed and utilized to segment
anatomic structures of interest from standard-of-care cross-

Table 2: LAA FD and RL values and results of statistical analysis (significance defined at α< 0.05).
Mean (95% CI)
No Past CVA/
TIA

P-Value for
Comparison

2.292

2.326

0.0519

(2.243 to 2.341)

(2.315 to 2.337)

Past CVA/TIA
LAA
FD
RL

4.319

4.319

(3.796 to 4.842)

(4.861 to 5.393)

Odds Ratio (95%
CI)

P-Value for
Regression

0.004

0.0548

(0.000 to 1.119)
0.033
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0.727
(0.541 to 0.977)

Area under the
curve (AUC)

P-Value for AUC
= 0.5

0.59

0.2322

(0.517 to 0.660)
0.0342

0.635

0.0168

(0.564 to 0.702)
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sectional imaging. Custom fractal analysis batch-processing
soft-ware derived from ImageJ (NIH [1]) created for this
investigation provides a scalable approach for volumetric
analysis from large datasets.
RL values were significantly lower in patients with prior
CVA/TIA and represented the only statistically significant
parameter in multivariate logistic regression analysis
incorporating LAA FD and individual parameters from
the CHA2DS2-VASc scoring system. RL measurements
involved two-dimensional measurements between two
iodinated structures and were less work-intensive and less
sensitive to variations in study quality, in comparison to LAA
FD calculations which depended upon three-dimensional
volumetric analysis. Furthermore, RL is feasible to obtain
using native measurement tools from standard-of- care
medical imaging digital access platforms such as the PACS
and therefore can be efficiently reported by radiologists in
CCTA study reports. Subjective investigator assessments of
perpendicular axes to each pulmonary venous ridge and the
shortest distances between the LAA and LSPV represent
possible sources of variation that should be considered
in interpreting such data. In this study, ground-truth RL
measurements were determined by statistical means from
observers and consensus.
Variations in RL may play a potential role in thrombogenic
flow within the LAA. The possible presence of muscular bands
or trabeculated surface irregularity within the pulmonary
venous ridge could also result in higher risk for thrombus
formation and subsequent thromboembolism. If RL is shown
to be a useful marker for thromboembolic risk in AF, then it
could be utilized for clinical scoring and to direct treatment
in AF.
Additional feasibility studies are warranted to further
assess clinical benefit and efficacious value-based resource
utilization of the time radiologists would spend during
manual semi-automated segmentation of the LAA to
ultimately obtain the LAA FD. The role of machine learning
and fully convoluted neural networks (FCNs) could provide
an automated, validated solution to LAA segmentation from
CCTA, as FCNs have already demonstrated success in the
segmentation of pancreatic structures on CT [24].
Nedios et al., proposed “tachycardiac-mediated thrombogenic flow” as a possible mechanism for increased
thromboembolic risk in patients with higher LAA “takeoff ”
with respect to the LSPV and LIPV [16]. If our findings
are confirmed in larger prospective studies, future studies
should investigate differential patterns of left atrial blood
flow in AF as RL varies through use of modalities such as
Doppler echocardiography and four-dimensional flow MRI
to identify a pathophysiologic thromboembolic mechanism
[25]. Electrophysiological analyses of the conductive features
of the pulmonary venous ridge may also be helpful to assess for
the presence of muscular bands or arrhythmogenic foci with
variant activation frequency within the pulmonary venous
ridge.
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Current clinical scoring criteria using the CHA2DS2VASc demonstrates modest efficacy in appropriately indicating
anticoagulation therapy in AF [5]. The P2-CHA2DS2-VASc
score has been validated as an improved scoring criterion
for stroke risk in AF by incorporating abnormal p-wave axis
from prothrombotic atrial remodeling in stroke risk as an
additional index for the administration of anticoagulation
[26]. The primary clinical application of RL would be to
identify patients with AF at increased CVA risk to achieve
early initiation of therapeutic anticoagulation. Larger studies
and further investigation of the pathophysiologic mechanisms
underlying LA thromboembolism in AF related to the RL
are necessary to clarify the utility of the RL to inform clinical
decision-making.
Our relatively small sample size of patients with prior
CVA/TIA and the overall precision of the LAA FD values
obtained render meaningful interpretation of our findings
difficult. The non-significant trend observed in these data
would suggest that a lower LAA FD is associated with prior
CVA/TIA, which contrasts with our initial hypothesis and
established pathophysiologic mechanisms of cardioembolic
CVA [7]. Variations in CCTA study quality and contrast dose
imposed artifact and spiculation into the semi-automated
volume-rendering LAA segmentations. The incorporation of
variable artifact and spiculation from CCTA studies constitutes
a confounding variable affecting the internal validity of the
LAA FD data. The manual cropping of LAA ostia during
semi-automated volume rendering additionally incorporates
a subjective component, which also threatens the validity of
these findings. Based on these findings, the authors conclude
that larger studies are necessary to clarify the role of the LAA
FD to predict CVA/TIA in AF.

Conclusion

LAA FD and RL are novel parameters derived from
standard-of-care CCTA imaging with potential utility to
refine clinical decision-making for patients with AF. In this
retrospective study, LAA FD values were similar between
patients with AF with and without prior CVA/TIA, whereas a
lower RL predicted prior CVA/TIA. These parameters should
be further investigated in larger and prospective studies to
clarify their utilities in refining clinical decision-making for
intermediate-risk patients with AF. In addition, future studies
should clarify possible pathophysiologic mechanisms related
to RL and LA thrombosis.
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